Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking semaglutide a day early does not trigger an emergency, but it does shift your injection schedule — and that matters more than most people realise. Semaglutide is a once-weekly medicine with a half-life of roughly seven days, meaning it accumulates gradually in your system. Injecting one day before your usual day does not double your dose or cause the medicine to spike dangerously, but it does bring your next scheduled dose closer, which can amplify side effects and subtly disrupts the rhythm your prescriber set. These are prescription-only medicines: semaglutide (Wegovy) is licensed for weight management and should always be used according to the guidance in the NHS semaglutide patient guide and the Patient Information Leaflet supplied with your pen.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the misconception worth correcting first. Because semaglutide accumulates slowly and its effects feel steady week to week, it is tempting to think a 24-hour deviation is trivial. It is not dangerous in an acute sense, but it is not neutral either. The medicine's pharmacokinetics mean that each dose adds to what is already circulating. When two doses arrive closer together than intended, the combined level is higher than your body has been titrated to tolerate. The result is often a flare of the gastrointestinal effects that typically settle between doses: nausea, reflux, loose stools, or low appetite suddenly sharper than usual.
The licensed once-weekly interval exists for a reason. Your prescriber chose your current dose on the assumption you inject on the same day each week. Shifting that day by one, and then injecting again on your new day seven days later, is a one-off adjustment your system can handle. Shifting it repeatedly compresses the schedule progressively, and that is where problems accumulate. If you have ever wondered about taking Wegovy two days early, the same principle applies with a wider gap, the effects compound further.
Worth checking: the semaglutide (Wegovy) overview at nume covers how the titration schedule is structured and why the weekly rhythm is central to how the medicine is meant to work.
The most common experience is a temporary worsening of side effects. Nausea is the headline, but people also report more pronounced fatigue, heavier reflux, or a stronger wave of low appetite in the 48 hours after the injection. These effects tend to mirror what many people felt when they first started treatment or moved up to a higher dose, which makes sense, because the pharmacological picture is similar: a slightly higher circulating level than the body expects at that moment.
For most people the discomfort settles within a day or two, and the following week returns to normal. Staying well hydrated matters more than usual. Eating small amounts of bland food rather than skipping meals altogether can help manage nausea without triggering further discomfort. None of that advice replaces what the Patient Information Leaflet or your prescriber tells you, these are general patterns, not personal instructions.
If side effects are severe, persistent beyond 48 hours, or include intense stomach pain that extends to your back, seek medical attention promptly. That last symptom can be a sign of pancreatitis, which the MHRA has highlighted as a known but uncommon serious side effect of GLP-1 medicines, report any suspected serious reaction through the MHRA Yellow Card scheme. Curious about other dose-related questions? There is further reading on what happens if you take too much semaglutide if that concern arises.
After an early injection, two instincts pull in opposite directions. One is to reset: treat the early day as your new injection day going forward, maintain a clean seven-day rhythm from here. The other is to delay the next dose to restore the original day, injecting on day eight or nine rather than day seven. Both can work, but they carry different implications.
Resetting is generally simpler. Your schedule moves forward by one day, your body has a consistent gap each week, and the titration plan your prescriber wrote continues undisturbed. Waiting an extra day or two beyond the seven-day mark is not harmful (semaglutide's long half-life means a brief extension of the interval will not erase efficacy) but if you stretch the gap too far, consistently, you may reduce the steady-state coverage the medicine provides.
Life gets in the way, and there is no shame in admitting that a holiday, a payday-Friday get-together, or a packed Monday morning made the usual day impossible. The important thing is what you do next: pick a clear new day and keep to it, or speak to your prescriber about formally changing your injection day. That conversation is exactly what the clinical review process at nume's consultation service is designed for. A related question many patients have is whether it is ever appropriate to inject semaglutide a day early deliberately, that page looks at planned schedule changes in detail.
Injection technique matters too, separately from timing. If you are reviewing your whole routine, choosing the right injection site for Wegovy is worth a read alongside this.
A single early dose, resetting your day, no unusual symptoms: that scenario does not require an urgent call. But some situations do warrant a conversation with whoever prescribed your treatment. Tell your prescriber if you have taken a dose more than a day early and are experiencing side effects that feel different or more intense than anything in your previous experience, if you have been adjusting your injection day repeatedly over several weeks without guidance, or if you are approaching a planned dose increase and an early injection has disrupted the timing around that step.
This matters more at higher doses. At 1.7mg or 2.4mg maintenance, the body has less margin for additional circulating semaglutide than it did at 0.25mg. The question of what to do after taking Wegovy one day early is subtly different at each stage of the titration, prescriber guidance keeps the plan calibrated to where you actually are. You can explore the broader weight-loss treatment landscape to understand how semaglutide sits alongside other options, or visit our frequently asked questions for answers to other common queries.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.